alexa
Reach Us 443308186230

GET THE APP

Dersleri yüzünden oldukça stresli bir ruh haline sikiş hikayeleri bürünüp özel matematik dersinden önce rahatlayabilmek için amatör pornolar kendisini yatak odasına kapatan genç adam telefonundan porno resimleri açtığı porno filmini keyifle seyir ederek yatağını mobil porno okşar ruh dinlendirici olduğunu iddia ettikleri özel sex resim bir masaj salonunda çalışan genç masör hem sağlık hem de huzur sikiş için gelip masaj yaptıracak olan kadını gördüğünde porn nutku tutulur tüm gün boyu seksi lezbiyenleri sikiş dikizleyerek onları en savunmasız anlarında fotoğraflayan azılı erkek lavaboya geçerek fotoğraflara bakıp koca yarağını keyifle okşamaya başlar
Glucose Toxicity: The Worldwide Problem And The All-natural Solution | 106465
ISSN: 2165-7904

Journal of Obesity & Weight Loss Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 1473

Journal of Obesity & Weight Loss Therapy received 1473 citations as per Google Scholar report

Journal of Obesity & Weight Loss Therapy peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Open J Gate
  • Genamics JournalSeek
  • Centre for Agriculture and Biosciences International (CABI)
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • CABI full text
  • Cab direct
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • University of Bristol
  • pubmed
Share This Page

Glucose toxicity: The worldwide problem and the all-natural solution

Joint Event on 12th International Conferences on Childhood Obesity and Nutrition & 3rd World Congress on Diabetes and Obesity

John F. Burd

Lysulin, Inc., USA

ScientificTracks Abstracts: J Obes Weight Loss Ther

Abstract
Glucose toxicity is an epidemic problem leading to the insulin resistance and the development of obesity, prediabetes and Type 2 diabetes in both children and adults. In addition to poor health and early death, this is costing our healthcare systems a fortune to treat diabetes and its complications. Glucose is not a passive bystander in our bloodstream but is a toxic and reactive compound. Glucose reacts with all of the proteins in our body forming Glycated Proteins. These glycated proteins progress to become what is known as Advanced Glycation End-products Advanced Glycation End-products or AGEs. These AGEs are known to be the culprits in the disease complications associated with diabetes including kidney failure, blindness, amputations and cardiovascular disease. Protein glycation is also be the cause of insulin resistance. Insulin resistance not only leads to high blood glucose levels in our bloodstream, but also leads to insulin depletion. When this happens, we may have to resort to injection of insulin in an attempt to keep our blood glucose levels in the normal range. There is now an all-natural solution to the glucose toxicity problem. In over 20 years of R&D and clinical studies, nutritional supplements have been proven to combat glucose toxicity. Three important supplements having this ability are the Lysine, zinc and vitamin C. Combining these three important supplements into one tablet makes a powerful weapon to combat glucose toxicity and protein glycation. This weapon is Lysulin. Unlike the available prescription drugs for type 2 diabetes which are directed at the symptoms of diabetes (high blood glucose), Lysulin is the first product directed at the problem, which is glucose toxicity and protein glycation. Clinical studies have proven that Lysulin lowers HbA1c better than the vast majority of prescription drugs. Current therapy for type 2 diabetes and the history of studies proving the effectiveness of Lysulin will be presented along with recent data from double blind placebo controlled studies with Lysulin.
Biography

John F. Burd is Founder & CEO of Lysulin, Inc, and has launched an all-natural, scientifically proven nutraceutical product proven to improve the health of people with diabetes. He was also the cofounder of Sabur Technology, Inc., developing a new non-invasive continuous glucose monitoring technology. Prior to Sabur, He was a General Partner of Windamere Venture Partners. He was previously President & CEO of DexCom, now the leader in continuing glucose monitoring for people with diabetes. He has authored over 40 publications and holds 35 patents. He graduated from Purdue University with a B.S. in Biochemistry, and earned an M.S. and Ph.D., also in Biochemistry, from the University of Wisconsin. In 2010, he was inducted into the American Association of Clinical Chemistry Hall of Fame and received the Ullman Prize for innovation in clinical chemistry.

E-mail: [email protected]

 

Top